2019 Update of the American College of Rheumatology/ Spondylitis
26 Sept 2019 Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and. Nonradiographic Axial Spondyloarthritis.
Guideline on the Clinical Investigation of Medicinal Products for the
12 Oct 2017 It should be considered as general guidance on the development of medicinal products for the treatment of axial spondyloarthritis and should be ...
The Treatment of Axial Spondyloarthritis
The Treatment of. Axial Spondyloarthritis. Best practice for the management of patients. Claire Harris Senior Physiotherapist
Pathway for use of biologic drugs for Axial Spondyloarthritis
Second line treatment for AS. Consider alternative Anti-TNF. Secukinumab (NICE TA 407). Ixekizumab (NICE TA 718). Assess response as per Box 3 and monitor
Secukinumab for treating non-radiographic axial spondyloarthritis
21 Jul 2021 Treatment for non-radiographic axial spondyloarthritis that is not controlled well enough with. NSAIDs is limited to TNF-alpha inhibitors ( ...
NICE
21 Jul 2021 Ixekizumab (Taltz Eli Lily) is indicated for 'the treatment of adult patients with active ankylosing spondylitis [radiographic axial ...
Biologic therapy for axial SpA (AS)
Axial Spondyloarthritis (axial SpA) is a painful form of inflammatory arthritis. Non-radiographic axial spondyloarthritis. Where x-ray changes are not present.
Golimumab for treating non-radiographic axial spondyloarthritis
Golimumab for treating non- radiographic axial spondyloarthritis. Technology appraisal guidance. Published: 10 January 2018 www.nice.org.uk/guidance/ta497.
Treatment of axial spondyloarthritis: an update
10 Mar 2022 Axial spondyloarthritis (axSpA) is an immune-mediated inflammatory disease predominantly ... The treatment of axial psoriatic arthritis and.
